Loracarbef - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for loracarbef and what is the scope of patent protection?
Loracarbef
is the generic ingredient in one branded drug marketed by King Pharms and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for loracarbef
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Clinical Trials: | 1 |
Patent Applications: | 5,187 |
Formulation / Manufacturing: | see details |
DailyMed Link: | loracarbef at DailyMed |
Recent Clinical Trials for loracarbef
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
James Graham Brown Cancer Center | Early Phase 1 |
Julio Ramirez | Early Phase 1 |
University of Louisville | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for loracarbef
US Patents and Regulatory Information for loracarbef
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pharms | LORABID | loracarbef | CAPSULE;ORAL | 050668-001 | Dec 31, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
King Pharms | LORABID | loracarbef | FOR SUSPENSION;ORAL | 050667-001 | Dec 31, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
King Pharms | LORABID | loracarbef | FOR SUSPENSION;ORAL | 050667-002 | Dec 31, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
King Pharms | LORABID | loracarbef | CAPSULE;ORAL | 050668-002 | Apr 5, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |